Literature DB >> 7729870

Selection of variant Borrelia burgdorferi isolates from mice immunized with outer surface protein A or B.

E Fikrig1, H Tao, S W Barthold, R A Flavell.   

Abstract

A nonclonal population of Borrelia burgdorferi N40 (passage 3) that survived protective immunity following challenge inoculation of outer surface protein (Osp) A- or B-hyperimmunized mice were characterized for the molecular basis of evasion of immunity. Two of six B. burgdorferi isolates, cultured from OspA-immunized mice, had antigenic diversity in the carboxyl terminus of OspA and did not bind to the protective OspA monoclonal antibody designated IXDII. However, OspA-immunized mice challenged with these variants were fully protected. Moreover, B. burgdorferi isolates with a point mutation in ospB, which results in a truncated OspB that does not bind to protective OspB monoclonal antibody 7E6C, were frequently enriched after infection of OspB-immunized mice. These studies suggest that the incomplete efficacy of an OspA- or OspB-based vaccine may be partly due to immunomediated in vivo selective pressure, resulting in the persistence of some spirochetes that do not bind to protective antibodies.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7729870      PMCID: PMC173206          DOI: 10.1128/iai.63.5.1658-1662.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Protection of mice against the Lyme disease agent by immunizing with recombinant OspA.

Authors:  E Fikrig; S W Barthold; F S Kantor; R A Flavell
Journal:  Science       Date:  1990-10-26       Impact factor: 47.728

2.  Selection of an escape variant of Borrelia burgdorferi by use of bactericidal monoclonal antibodies to OspB.

Authors:  J L Coleman; R C Rogers; J L Benach
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

3.  Molecular mapping of Osp-A mediated immunity against Borrelia burgdorferi, the agent of Lyme disease.

Authors:  J E Sears; E Fikrig; T Y Nakagawa; K Deponte; N Marcantonio; F S Kantor; R A Flavell
Journal:  J Immunol       Date:  1991-09-15       Impact factor: 5.422

4.  Elimination of Borrelia burgdorferi from vector ticks feeding on OspA-immunized mice.

Authors:  E Fikrig; S R Telford; S W Barthold; F S Kantor; A Spielman; R A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

5.  Borrelia burgdorferi strain 25015: characterization of outer surface protein A and vaccination against infection.

Authors:  E Fikrig; S W Barthold; D H Persing; X Sun; F S Kantor; R A Flavell
Journal:  J Immunol       Date:  1992-04-01       Impact factor: 5.422

6.  Active immunization of hamsters against experimental infection with Borrelia burgdorferi.

Authors:  R C Johnson; C Kodner; M Russell
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

7.  Monoclonal antibodies specific for the outer surface protein A (OspA) of Borrelia burgdorferi prevent Lyme borreliosis in severe combined immunodeficiency (scid) mice.

Authors:  U E Schaible; M D Kramer; K Eichmann; M Modolell; C Museteanu; M M Simon
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  Recombinant outer surface protein a from Borrelia burgdorferi induces antibodies protective against spirochetal infection in mice.

Authors:  M M Simon; U E Schaible; M D Kramer; C Eckerskorn; C Museteanu; H K Müller-Hermelink; R Wallich
Journal:  J Infect Dis       Date:  1991-07       Impact factor: 5.226

10.  Vaccination against Lyme disease caused by diverse Borrelia burgdorferi.

Authors:  E Fikrig; S R Telford; R Wallich; M Chen; Y Lobet; F R Matuschka; R B Kimsey; F S Kantor; S W Barthold; A Spielman; R A Flavell
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307

View more
  10 in total

1.  Surface exposure and species specificity of an immunoreactive domain of a 66-kilodalton outer membrane protein (P66) of the Borrelia spp. that cause Lyme disease.

Authors:  J Bunikis; L Noppa; Y Ostberg; A G Barbour; S Bergström
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

2.  Vaccination with the ospA- and ospB-Negative Borrelia burgdorferi Strain 50772 Provides Significant Protection against Canine Lyme Disease.

Authors:  Rhonda L LaFleur; Steven M Callister; Jennifer C Dant; Terri L Wasmoen; Dean A Jobe; Steven D Lovrich
Journal:  Clin Vaccine Immunol       Date:  2015-05-13

3.  Borrelia burgdorferi escape mutants that survive in the presence of antiserum to the OspA vaccine are killed when complement is also present.

Authors:  M Solé; C Bantar; K Indest; Y Gu; R Ramamoorthy; R Coughlin; M T Philipp
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

4.  Active and passive immunity against Borrelia burgdorferi decorin binding protein A (DbpA) protects against infection.

Authors:  M S Hanson; D R Cassatt; B P Guo; N K Patel; M P McCarthy; D W Dorward; M Höök
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

Review 5.  Experimental immunization against Lyme borreliosis with recombinant Osp proteins: an overview.

Authors:  A Sadziene; A G Barbour
Journal:  Infection       Date:  1996 Mar-Apr       Impact factor: 3.553

6.  One-year duration of immunity induced by vaccination with a canine Lyme disease bacterin.

Authors:  Rhonda L LaFleur; Steven M Callister; Jennifer C Dant; Dean A Jobe; Steven D Lovrich; Thomas F Warner; Terri L Wasmoen; Ronald F Schell
Journal:  Clin Vaccine Immunol       Date:  2010-03-17

7.  Outer surface protein C (OspC), but not P39, is a protective immunogen against a tick-transmitted Borrelia burgdorferi challenge: evidence for a conformational protective epitope in OspC.

Authors:  R D Gilmore; K J Kappel; M C Dolan; T R Burkot; B J Johnson
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

Review 8.  Outer membrane proteins of pathogenic spirochetes.

Authors:  Paul A Cullen; David A Haake; Ben Adler
Journal:  FEMS Microbiol Rev       Date:  2004-06       Impact factor: 16.408

9.  Bacterin that induces anti-OspA and anti-OspC borreliacidal antibodies provides a high level of protection against canine Lyme disease.

Authors:  Rhonda L LaFleur; Jennifer C Dant; Terri L Wasmoen; Steven M Callister; Dean A Jobe; Steven D Lovrich; Thomas F Warner; O Abdelmagid; Ronald F Schell
Journal:  Clin Vaccine Immunol       Date:  2008-12-03

10.  The immunoglobulin (IgG) antibody response to OspA and OspB correlates with severe and prolonged Lyme arthritis and the IgG response to P35 correlates with mild and brief arthritis.

Authors:  E Akin; G L McHugh; R A Flavell; E Fikrig; A C Steere
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.